Pàgina inicial > Resultats de la cerca: Insulin
  Consells de cerca
Cerca simple
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 81 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.45 segons. 
1.
13 p, 1.2 MB Arterial Stiffness in Type 1 Diabetes : The Case for the Arterial Wall Itself as a Target Organ / González-Clemente, José-Miguel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Cano, Albert (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Albert Fàbregas, Lara (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Giménez-Palop, Olga (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Romero Gregori, Ana (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Berlanga Escalera, Eugenio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Vendrell, Joan (Hospital Universitari Joan XXIII de Tarragona) ; Llauradó, Gemma (Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona
Arterial stiffness (AS) integrates the cumulative burden of known and unknown cardiovascular risk factors on the elastic wall of large arteries along the lifespan of an individual. As a marker of vascular aging, AS is an independent predictor of cardiovascular events and improves cardiovascular risk prediction when added to the Framingham Risk Score. [...]
2021 - 10.3390/jcm10163616
Journal of clinical medicine, Vol. 10 (august 2021)  
Registre complet - Creative Commons
2.
17 p, 3.1 MB Effects of a carob-pod-derived sweetener on glucose metabolism / Lambert, Carmen (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Cubedo, Judit (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; López-Bernal, Sergi (Institut d'Investigació Biomèdica Sant Pau) ; Rocha, Milagros (Hospital Universitari Doctor Peset (València)) ; Hernández-Mijares, Antonio (Universitat de València) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Patients with type 2 diabetes mellitus (T2DM) have a higher incidence of cardiovascular (CV) events. The ingestion of high-glycemic index (GI) diets, specially sweetened beverage consumption, has been associated with the development of T2DM and CV disease. [...]
2018 - 10.3390/nu10030271
Nutrients, Vol. 10 Núm. 3 (march 2018) , p. 271  
Registre complet - Creative Commons
3.
255 p, 4.1 MB Role of the Intestinal Microbiota and metabolomic profile in Type 2 Diabetes : effects on risk factors for comorbidities associated with this pathology and insulin resistance of specific organs and tissues / Xiao, Xingpeng ; Herance Camacho, Jose Raul, dir. ; Palomino Schatzlein, Martina, dir. ; Chillón Rodríguez, Miguel, dir.
Antecedents: La diabetis de tipus 2 (DM2) es considera una creixent epidèmia mundial, associada a diverses comorbiditats, que inclouen les malalties cardiovasculars, malalties del fetge o demències, generant un nombre important de morts cada any. [...]
Antecedentes: La diabetes tipo 2 (DM2) es una epidemia mundial con una incidencia creciente, que puede generar una serie de comorbilidades, como las enfermedades cardiovasculares, la enfermedad del hígado graso no alcohólico o la demencia, provocando muchas muertes cada año. [...]
2023  
Registre complet -
4.
8 p, 594.7 KB The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes : Achieving HbA1c targets with basal insulin in a real-world setting / Meneghini, Luigi F. (Parkland Health & Hospital System) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Orsi, Emanuela (Fondazione Ca' Granda IRCCS) ; Lalic, Nebojsa M. (University of Belgrade) ; Cali, Anna M.G. (Sanofi) ; Westerbacka, Jukka (Sanofi) ; Stella, Peter (Sanofi) ; Candelas, Christophe (Sanofi) ; Pilorget, Valerie (Sanofi) ; Perfetti, Riccardo (Sanofi) ; Khunti, Kamlesh (University of Leicester) ; Universitat Autònoma de Barcelona
To describe in a real-world setting the achievement of physician-selected individualized HbA1c targets in individuals with type 2 diabetes, newly or recently initiated with basal insulin, and the association of hypoglycaemia with target achievement. [...]
2019 - 10.1111/dom.13673
Diabetes, Obesity and Metabolism, Vol. 21 Núm. 6 (june 2019) , p. 1429-1436  
Registre complet - Creative Commons
5.
12 p, 1.0 MB The importance of the initial period of basal insulin titration in people with diabetes / Khunti, Kamlesh (University of Leicester) ; Giorgino, Francesco (University of Bari Aldo Moro) ; Berard, Lori (Winnipeg Regional Health Authority) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Harris, Stewart B. (Western University) ; Universitat Autònoma de Barcelona
Achieving target glycaemic control is essential in people with diabetes to minimize the risk of long-term complications, and many people with type 2 diabetes will ultimately require basal insulin (BI) therapy to achieve their individualized glycaemic targets. [...]
2020 - 10.1111/dom.13946
Diabetes, Obesity and Metabolism, Vol. 22 Núm. 5 (january 2020) , p. 722-733  
Registre complet - Creative Commons
6.
13 p, 1.6 MB Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus / Freemantle, Nick (University College London) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Giaccari, Andrea (Università Cattolica del Sacro Cuore) ; Bailey, Timothy (AMCR Institute) ; Roussel, Ronan (UFR de Médecine. Paris University) ; Franco, Denise (CPCLIN Clinical Research Center) ; Berthou, Baptiste (IT&M Stats) ; Pilorget, Valerie (Sanofi) ; Westerbacka, Jukka (Sanofi) ; Bosnyak, Zsolt (Sanofi) ; Bonnemaire, Mireille (Sanofi) ; Cali, Anna M.G (Sanofi) ; Nguyên-Pascal, My-Liên (Sanofi) ; Penfornis, Alfred (Corbeil-Essonnes and Université Paris Sud) ; Perez-Maraver, Manuel (Hospital Universitari de Bellvitge) ; Seufert, Jochen (University of Freiburg) ; Sullivan, Sean D. (University of Washington) ; Wilding, John (University of Liverpool) ; Wysham, Carol (Multicare Rockwood Clinic) ; Davies, Melanie (University of Leicester) ; Universitat Autònoma de Barcelona
To compare real-world outcomes with newer (insulin glargine 300 U/mL; Gla-300) versus standard of care (SoC) basal insulins (BIs) in the REACH (insulin-naïve; NCT02967224) and REGAIN (basal insulin-treated; NCT02967211) studies in participants with uncontrolled type 2 diabetes (T2DM) in Europe and Brazil. [...]
2020 - 10.1080/03007995.2019.1708287
Current Medical Research and Opinion, Vol. 36 Núm. 4 (february 2020) , p. 571-581  
Registre complet - Creative Commons
7.
8 p, 533.2 KB Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : Protocol of REALI project / Freemantle, N. (University College London) ; Bonadonna, Riccardo C (University of Parma) ; Gourdy, P. (Paul Sabatier University) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Mueller-Wieland, D. (University Hospital Aachen (Alemanya)) ; Bigot, Gregory (IVIDATA) ; Ciocca, A. (Sanofi SA) ; Mauquoi, C. (IDDI SA) ; Rollot, M. (Quinten) ; Bonnemaire, Mireille (Sanofi SA) ; Universitat Autònoma de Barcelona
Type 2 diabetes mellitus (T2DM) is a common and heterogeneous disease. Using advanced analytic approaches to explore real-world data may identify different disease characteristics, responses to treatment and progression patterns. [...]
2020 - 10.1136/bmjopen-2019-033659
BMJ open, Vol. 10 Núm. 4 (28 2020) , p. 201903365  
Registre complet - Creative Commons
8.
12 p, 486.3 KB Biomarkers in Heart Failure with Preserved Ejection Fraction / Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santiago, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder developing from multiple aetiologies with overlapping pathophysiological mechanisms. HFpEF diagnosis may be challenging, as neither cardiac imaging nor physical examination are sensitive in this situation. [...]
2022 - 10.15420/cfr.2021.37
Cardiac Failure Review, Vol. 8 (june 2022)  
Registre complet - Creative Commons
9.
18 p, 5.3 MB On the occasion of the centennial of the Nobel Prize in Physiology or Medicine, 1923: Nicolae C. Paulescu-between scientific creativity and political fanatism / Leiva Hidalgo, Alberto de (Universitat Autònoma de Barcelona. Departament de Medicina) ; de Leiva‑Pérez, Alejandra (Fundación DIABEM)
Since the Nobel Prize in Physiology or Medicine was awarded in 1923 to FG Banting and JJR Macleod, many voices have been raised against this decision. The bitterest protest was that of the Romanian scientist Nicolae C. [...]
2023 - 10.1007/s00592-023-02136-6
Acta Diabetologica, July 2023  
Registre complet - Creative Commons
10.
16 p, 2.3 MB The Nobel Prize of Physiology or Medicine, 1923: controversies on the discovery of the antidiabetic hormone / Leiva Hidalgo, Alberto de (Universitat Autònoma de Barcelona. Departament de Medicina) ; de Leiva‑Pérez, Alejandra (Fundació DIABEM)
To analyze the main contributions to the discovery of the antidiabetic hormone in the period between 1889, the year in which Oskar Minkowski demonstrated that complete pancreatectomy in dogs caused diabetes, and the year 1923, the date in which the clinical use of insulin was consolidated. [...]
2023 - 10.1007/s00592-023-02098-9
Acta Diabetologica, Vol. 60 (June 2023)  
Registre complet - Creative Commons

Dipòsit Digital de Documents de la UAB : 81 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem